
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic cell biology and its role in tumor immunotherapy
Ying-Ying Wang, Ying Xiang, Victoria W. Xin, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 318
Ying-Ying Wang, Ying Xiang, Victoria W. Xin, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 318
Showing 1-25 of 318 citing articles:
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 481
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 481
Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu, Tian Zhang, Lei Zheng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 433
Shaoming Zhu, Tian Zhang, Lei Zheng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 433
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 262
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 262
Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
Xin Li, Tuying Yong, Zhaohan Wei, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 175
Xin Li, Tuying Yong, Zhaohan Wei, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 175
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment
Weina Yu, Qingyang Lei, Li Yang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 155
Weina Yu, Qingyang Lei, Li Yang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 155
Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation
Vaishali Chugh, K. Vijaya Krishna, Abhay Pandit
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17080-17123
Open Access | Times Cited: 118
Vaishali Chugh, K. Vijaya Krishna, Abhay Pandit
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17080-17123
Open Access | Times Cited: 118
Research progress on dendritic cell vaccines in cancer immunotherapy
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 118
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 118
Natural killer cells: a promising immunotherapy for cancer
Junfeng Chu, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 113
Junfeng Chu, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 113
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
Taghreed Hirz, Shenglin Mei, Hirak Sarkar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 109
Taghreed Hirz, Shenglin Mei, Hirak Sarkar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 109
Targeting macrophages in hematological malignancies: recent advances and future directions
Wei Li, Fang Wang, Rongqun Guo, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 97
Wei Li, Fang Wang, Rongqun Guo, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 97
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Immunogenic cell death in cancer: concept and therapeutic implications
Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
Bashdar Mahmud Hussen, Goran Sedeeq Hama Faraj, Mohammed Fatih Rasul, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 76
Bashdar Mahmud Hussen, Goran Sedeeq Hama Faraj, Mohammed Fatih Rasul, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 76
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 69
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 69
Genetically Engineering Cell Membrane‐Coated BTO Nanoparticles for MMP2‐Activated Piezocatalysis‐Immunotherapy
Qingshuang Tang, Suhui Sun, Ping Wang, et al.
Advanced Materials (2023) Vol. 35, Iss. 18
Closed Access | Times Cited: 68
Qingshuang Tang, Suhui Sun, Ping Wang, et al.
Advanced Materials (2023) Vol. 35, Iss. 18
Closed Access | Times Cited: 68
Self-triggered thermoelectric nanoheterojunction for cancer catalytic and immunotherapy
Yuan Xue, Yong Kang, Jinrui Dong, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Yuan Xue, Yong Kang, Jinrui Dong, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Advances in dendritic cell vaccination therapy of cancer
Sajad Najafi, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114954-114954
Open Access | Times Cited: 53
Sajad Najafi, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114954-114954
Open Access | Times Cited: 53
Tumor microenvironment‐responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy
Beibei Chen, Kangli Guo, Xiaoyi Zhao, et al.
Exploration (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 51
Beibei Chen, Kangli Guo, Xiaoyi Zhao, et al.
Exploration (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 51
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 48
Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 48
Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade
Saeid Moghassemi, Arezoo Dadashzadeh, Maria João Sousa, et al.
Bioactive Materials (2024) Vol. 36, pp. 126-156
Open Access | Times Cited: 31
Saeid Moghassemi, Arezoo Dadashzadeh, Maria João Sousa, et al.
Bioactive Materials (2024) Vol. 36, pp. 126-156
Open Access | Times Cited: 31
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 30
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 30
Transformable Supramolecular Self‐Assembled Peptides for Cascade Self‐Enhanced Ferroptosis Primed Cancer Immunotherapy
He Wang, Di Jiao, Dexiang Feng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 26
He Wang, Di Jiao, Dexiang Feng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 26
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 25
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 25